Clinical Laserthermia Systems AB (publ) (CLS-B) — Financial Flexibility Index
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Financial Flexibility Index of -0.97x as of December 2025. Free cash flow of Skr-9.71 Million (operating CF Skr-10.69 Million minus capex Skr982.00K) represents -1% of total liabilities (Skr10.00 Million). Check Clinical Laserthermia Systems AB (publ) strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clinical Laserthermia Systems AB (publ) Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Clinical Laserthermia Systems AB (publ) across 18 annual periods. See CLS-B working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Clinical Laserthermia Systems AB (publ) (2008–2025)
Year-by-year free cash flow to debt coverage for Clinical Laserthermia Systems AB (publ). For the full company profile including market capitalisation, see market value of Clinical Laserthermia Systems AB (publ).
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.05x | Skr-30.50 Million | Skr-33.20 Million | Skr10.00 Million | ▲ +27.3% |
| 2024 | -4.19x | Skr-53.99 Million | Skr-56.45 Million | Skr12.88 Million | ▲ +2.3% |
| 2023 | -4.29x | Skr-60.96 Million | Skr-66.45 Million | Skr14.20 Million | ▼ -155.0% |
| 2022 | -1.68x | Skr-70.13 Million | Skr-70.69 Million | Skr41.64 Million | ▼ -16.9% |
| 2021 | -1.44x | Skr-65.62 Million | Skr-66.17 Million | Skr45.55 Million | ▲ +20.3% |
| 2020 | -1.81x | Skr-55.06 Million | Skr-55.41 Million | Skr30.47 Million | ▼ -47.6% |
| 2019 | -1.22x | Skr-38.77 Million | Skr-39.12 Million | Skr31.67 Million | ▲ +72.3% |
| 2018 | -4.43x | Skr-36.35 Million | Skr-38.72 Million | Skr8.21 Million | ▼ -168.1% |
| 2017 | -1.65x | Skr-19.71 Million | Skr-24.39 Million | Skr11.94 Million | ▲ +6.5% |
| 2016 | -1.77x | Skr-18.09 Million | Skr-19.63 Million | Skr10.24 Million | ▲ +70.5% |
| 2015 | -5.98x | Skr-16.78 Million | Skr-18.68 Million | Skr2.81 Million | ▼ -141.3% |
| 2014 | -2.48x | Skr-13.33 Million | Skr-15.74 Million | Skr5.38 Million | ▲ +51.4% |
| 2013 | -5.10x | Skr-15.86 Million | Skr-18.30 Million | Skr3.11 Million | ▼ -51.6% |
| 2012 | -3.36x | Skr-9.99 Million | Skr-12.05 Million | Skr2.97 Million | ▼ -75.5% |
| 2011 | -1.92x | Skr-4.17 Million | Skr-5.96 Million | Skr2.17 Million | ▲ +10.6% |
| 2010 | -2.14x | Skr-3.01 Million | Skr-4.92 Million | Skr1.41 Million | ▼ -424.7% |
| 2009 | 0.66x | Skr1.04 Million | Skr-2.28 Million | Skr1.57 Million | ▼ -37.2% |
| 2008 | 1.05x | Skr1.94 Million | Skr-69.30K | Skr1.85 Million | — |